Jump Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Buy
388,090
+37,951
+11% +$146K 0.02% 872
2026
Q1
$798K Sell
350,139
-172,257
-33% -$546K 0.01% 1021
2025
Q4
$2.09M Buy
522,396
+197,320
+61% +$1.1M 0.03% 660
2025
Q3
$2.75M Buy
+325,076
New +$3.15M 0.03% 614
2024
Q3
Sell
-56,062
Closed -$1.07M 1780
2024
Q2
$1.07M Buy
56,062
+35,454
+172% +$905K 0.02% 785
2024
Q1
$676K Buy
+20,608
New +$658K 0.02% 1021
2023
Q3
Sell
-24,604
Closed -$746K 1959
2023
Q2
$746K Buy
+24,604
New +$796K 0.03% 832
2022
Q4
Sell
-71,129
Closed -$2.56M 1701
2022
Q3
$2.56M Buy
71,129
+37,505
+112% +$1.32M 0.1% 300
2022
Q2
$1.03M Buy
+33,624
New +$980K 0.04% 551
2021
Q1
Sell
-11,100
Closed -$178K 1032
2020
Q4
$178K Buy
+11,100
New +$147K 0.03% 799

Other funds holding EVH

Jump Financial's EVH Position: Q2 2026 in Review

Jump Financial increased its Evolent Health (EVH) stake by 11% in Q2 2026, buying an estimated $146K and bringing the position to 388,090 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #872.

Jump Financial first reported a position in EVH in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.75M in Q3 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Jump Financial held 388,090 shares of Evolent Health worth $2.1M as of Q2 2026.
  • Jump Financial bought 37,951 Evolent Health shares in Q2 2026, an estimated $146K.
  • Evolent Health made up 0.02% of Jump Financial's portfolio in Q2 2026, its #872 holding.
  • Jump Financial first reported a position in Evolent Health in Q4 2020 and has held it in 10 quarters since.
  • Jump Financial's Evolent Health position peaked at $2.75M in Q3 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.